Pre-treatment Factors for the Development of Chronic Pain in Low Back Pain Patients
1 other identifier
observational
58
1 country
1
Brief Summary
The purpose of the project is to associate pre-treatment pain sensitivity level, levels of pain catastrophizing and levels of The Subgroups for Targeted Treatment (STarT) Back Screening Tool in patients with acute low back pain and patients' progression after 12 weeks of treatment by general practitioners.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 31, 2017
CompletedStudy Start
First participant enrolled
April 3, 2017
CompletedFirst Posted
Study publicly available on registry
April 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2018
CompletedMay 10, 2019
May 1, 2019
1.6 years
March 31, 2017
May 9, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Roland Morris Disability Questionnaire, RMDQ
Change in the Roland-Morris Questionnaire (RMDQ) is one of the most widely used questionnaires for back pain. The RMDQ is a self-administered disability questionnaire consisting of 24 questions. The questions are related specifically to physical functions likely to be affected by low back pain. Each item is qualified with the phrase "because of my back pain" to distinguish back pain disability from disability due to other causes. When completing the RMDQ, the respondents are asked to tick a statement if it applies to them on that particular day.
12 weeks follow-up
Secondary Outcomes (7)
The StarT Back Screening Tool
Baseline, 12 weeks follow-up
The Pain Catastrophizing Scale
Baseline, 12 weeks follow-up
Predicting the Inception of Chronic Pain
Baseline, 12 weeks follow-up
Basic information
Baseline, 12 weeks follow-up
Assessment of the Pain Area
Baseline, 12 weeks follow-up
- +2 more secondary outcomes
Interventions
Patients are treated based on their symptoms and the research group does not interfere with this.
Eligibility Criteria
The subjects will be recruited through general practitioners in The North Denmark Region. When a patient with low back pain reports to his/her general practitioner, the doctor will present the project to the patient, and in case the patient shows interest, the doctor asks him/her to contact the contact person of the study. Thus, the recruitment does not take place through advertisements, but through the normal patient flow in the general practice.
You may qualify if:
- Patients with low back pain, who have a mobile phone.
You may not qualify if:
- Pregnancy
- Drug addiction defined as the use of cannabis, opioids or other drugs
- Alcohol addiction
- Lack of ability to cooperate
- Surgery to the spine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aalborg Universitylead
- Research Unit for General Practice in Aalborgcollaborator
Study Sites (1)
Lægerne Sløjfen
Aalborg, Aalborg East, 9220, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Martin B Jensen, MD, PhD
Research Unit for General Practice in Aalborg, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
March 31, 2017
First Posted
April 12, 2017
Study Start
April 3, 2017
Primary Completion
November 6, 2018
Study Completion
November 6, 2018
Last Updated
May 10, 2019
Record last verified: 2019-05
Data Sharing
- IPD Sharing
- Will not share